Sipagladenant
Product Specifications
UNSPSC Description
Sipagladenant (Compound I) is an orally active adenosine receptor A2A inverse agonist[1]. Sipagladenant can be used in frontal lobe dysfunction research[2].
Target Antigen
Adenosine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/sipagladenant.html
Solubility
DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
O=C(C1=CN=C(C)C=C1)NC2=NC(C3=CC=CO3)=C(C(C4CCOCC4)=O)S2
Molecular Weight
397.45
References & Citations
[1]https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/pl127.pdf?sfvrsn=8544ca1e_3&download=true|[2]Horita, Takako. THERAPEUTIC AGENT FOR FRONTAL LOBE DYSFUNCTION, WO2016148308A1.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-147400/Sipagladenant-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-147400/Sipagladenant-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
858979-50-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6472827-01 0.2 mL
DOK2, CT (Docking Protein 2, Downstream Of Tyrosine Kinase 2, p56(dok-2)) (Azide free) (HRP)
Ask
View Details 
MBS6472827-02 5x 0.2 mL
DOK2, CT (Docking Protein 2, Downstream Of Tyrosine Kinase 2, p56(dok-2)) (Azide free) (HRP)
Ask
View Details 